S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Santarus to Hold Fourth Quarter and Full Year 2012 Financial Results Conference Call on March 4 (2013/2/19)|
|Santarus to Hold First Quarter 2013 Financial Results Conference Call on May 6 (2013/4/22)|
|Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for CYCLOSET® (bromocriptine mesylate) for the Management of Type 2 Diabetes (2013/3/6)|
|Santarus Reports Fourth Quarter and Full Year 2012 Financial Results (2013/3/4)|
|Santarus Reports First Quarter 2013 Financial Results (2013/5/6)|
|Santarus and Pharming Announce Submission of RUCONEST Biologics License Application to FDA (2013/4/17)|
|Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting (2013/5/17)|
|Santarus Announces Publication in Gut of Results from UCERIS (budesonide) European Pivotal Clinical Study (2013/3/18)|
|Santarus Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder (2013/5/9)|
|Santarus Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder (2013/5/10)|
Click above to view more mutual fund data and stats for snts - Santarus, Inc..